Page last updated: 2024-08-24

temoporfin and Experimental Neoplasms

temoporfin has been researched along with Experimental Neoplasms in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (37.50)	18.2507
2000's	7 (43.75)	29.6817
2010's	2 (12.50)	24.3611
2020's	1 (6.25)	2.80

Authors

Authors	Studies
Boniewska-Bernacka, E; Dyrda, G; Janas, K; Słota, R	1
Bezdetnaya, L; Dumas, D; Filipe, V; François, A; Gräfe, S; Guillemin, F; Hupont, S; Jiskoot, W; Lassalle, HP; Reshetov, V; Zorin, V	1
Bezdetnaya, L; D'Hallewin, MA; Dumas, D; Gräfe, S; Guillemin, F; Lassalle, HP	1
Baas, P; Cramers, P; Dalesio, O; Oppelaar, H; Ruevekamp, M; Stewart, FA	1
Bourré, L; Ferrand, Y; Lajat, Y; Odobel, F; Patrice, T; Simonneaux, G; Thibaut, S	1
Brown, SB; Jones, HJ; Vernon, DI	1
Braichotte, D; Folli, S; Glanzmann, T; Monnier, P; Savary, JF; Van den Bergh, H; Wagnieres, G; Westermann, P	1
Oppelaar, H; Oussoren, YG; Schuitmaker, JJ; Stewart, FA; van Geel, IP	1
Oppelaar, H; Oussoren, YG; Stewart, FA; van der Valk, MA; van Geel, IP	1
Blant, SA; Fontolliet, C; Monnier, P; van den Bergh, H; Wagnières, G; Woodtli, A	1
Foultier, MT; Gouyette, A; Lenz, P; Morlet, L; Patrice, T; Stewart, C; Vonarx, V	1
Altermatt, HJ; Althaus, U; Krueger, T; Li, Q; Lim, CK; Reynolds, B; Ris, HB	1
Bezdetnaya, LN; Brault, D; Guillemin, F; Melnikova, VO; Potapenko, AY	1
Korbelik, M; Sun, J	1
Bríza, T; Dolenský, B; Dvorák, M; Kaplánek, R; Kejík, Z; Král, V; Králová, J; Martásek, P; Moserová, I; Poucková, P; Vasek, P	1
Chen, DY; Chen, ZL; Gao, YH; Margetić, D; Srdanović, S; Yan, YJ	1

Trials

1 trial(s) available for temoporfin and Experimental Neoplasms

Article	Year
Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths. International journal of cancer, 1995, Oct-09, Volume: 63, Issue:2 Topics: Aged; Animals; Carcinoma, Squamous Cell; Humans; Male; Mesoporphyrins; Mice; Mice, Nude; Middle Aged; Mouth Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Spectrometry, Fluorescence	1995

Article

Year

Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths.

International journal of cancer, 1995, Oct-09, Volume: 63, Issue:2

Topics: Aged; Animals; Carcinoma, Squamous Cell; Humans; Male; Mesoporphyrins; Mice; Mice, Nude; Middle Aged; Mouth Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Spectrometry, Fluorescence

1995

Other Studies

15 other study(ies) available for temoporfin and Experimental Neoplasms

Article	Year
Porphyrin and phthalocyanine photosensitizers designed for targeted photodynamic therapy of colorectal cancer. Bioorganic & medicinal chemistry, 2021, 01-15, Volume: 30 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Isoindoles; Mice; Molecular Structure; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Structure-Activity Relationship	2021
Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo. International journal of nanomedicine, 2013, Volume: 8 Topics: Animals; HT29 Cells; Humans; Light; Liposomes; Mesoporphyrins; Mice; Nanocapsules; Neoplasms, Experimental; Particle Size; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Tissue Distribution; Treatment Outcome	2013
Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. Journal of controlled release : official journal of the Controlled Release Society, 2009, Mar-04, Volume: 134, Issue:2 Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Female; Liposomes; Mammary Neoplasms, Animal; Mesoporphyrins; Mice; Mice, Nude; Neoplasms, Experimental; Phosphatidylglycerols; Photochemotherapy; Photosensitizing Agents	2009
Foscan uptake and tissue distribution in relation to photodynamic efficacy. British journal of cancer, 2003, Jan-27, Volume: 88, Issue:2 Topics: Animals; Carbon Isotopes; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Light; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Tissue Distribution	2003
Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin. Bioorganic & medicinal chemistry letters, 2003, Mar-10, Volume: 13, Issue:5 Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Mesoporphyrins; Mice; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Reference Standards; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution; Tumor Cells, Cultured	2003
Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. British journal of cancer, 2003, Jul-21, Volume: 89, Issue:2 Topics: Animals; Disease Models, Animal; Drug Administration Schedule; Fibrosarcoma; Half-Life; Kinetics; Male; Mesoporphyrins; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Rats	2003
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. British journal of cancer, 1995, Volume: 72, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Female; Hematoporphyrin Derivative; Mesoporphyrins; Mice; Mice, Inbred C3H; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Radiation-Sensitizing Agents; Rubidium; Rubidium Radioisotopes	1995
Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin. International journal of cancer, 1995, Jan-27, Volume: 60, Issue:3 Topics: Animals; Female; Hematoporphyrin Derivative; Mesoporphyrins; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Photosensitizing Agents; Skin	1995
In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin. Photochemistry and photobiology, 1996, Volume: 64, Issue:6 Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Mesocricetus; Mesoporphyrins; Mouth Neoplasms; Neoplasms, Experimental; Photochemotherapy; Radiation-Sensitizing Agents	1996
In vitro and in vivo spectrofluorometry of a water-soluble meta-(tetrahydroxyphenyl)chlorin (m-THPC) derivative. Journal of photochemistry and photobiology. B, Biology, 1997, Volume: 39, Issue:3 Topics: Animals; Antineoplastic Agents; Cytoplasm; Flow Cytometry; Humans; In Vitro Techniques; Kinetics; Male; Mesoporphyrins; Mice; Mice, Nude; Muscles; Neoplasms, Experimental; Polyethylene Glycols; Radiation-Sensitizing Agents; Skin; Spectrometry, Fluorescence	1997
Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology. International journal of cancer, 1998, Jun-10, Volume: 76, Issue:6 Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Female; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous	1998
Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox. International journal of cancer, 2000, Dec-01, Volume: 88, Issue:5 Topics: Animals; Antineoplastic Agents; Antioxidants; Chromans; Disease Models, Animal; Drug Interactions; Female; HT29 Cells; Humans; Mesoporphyrins; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous	2000
Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. International journal of cancer, 2001, Jul-15, Volume: 93, Issue:2 Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Disease Models, Animal; Female; HT29 Cells; Humans; Immunotherapy, Adoptive; Killer Cells, Natural; Mesoporphyrins; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Photochemotherapy; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001
Glycol porphyrin derivatives as potent photodynamic inducers of apoptosis in tumor cells. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Flow Cytometry; Glycols; Humans; Injections, Intravenous; Mice; Mice, Nude; Molecular Structure; Molecular Weight; Neoplasms, Experimental; Photochemotherapy; Porphyrins; Stereoisomerism; Time Factors; Xenograft Model Antitumor Assays	2008
The photodynamic activity of 13 Bioorganic & medicinal chemistry letters, 2018, 06-01, Volume: 28, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Humans; Mice; Molecular Structure; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Porphyrins; Pyridines; Structure-Activity Relationship	2018